Status: Recruiting
Acute Treatment of Vestibular Migraine by Rimegepant
To evaluate whether rimegepant improves acute vestibular symptoms and accompanying discomforts in patients with vestibular migraine.
Participants needed: 80
Trial details
Phase: Phase 4Age: 18-60Biological sex: AllType: InterventionalSponsor: Wensheng QuUpdated: Oct 13, 2026Locations: 1
Eligibility criteria
Age 18-60 years, male or female. [+3]
Presence of other disorders causing acute vestibular symptoms (e.g., Ménière's d... [+10]